EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Sarcopenia in Older Patients with Newly Diagnosed Multiple Myeloma

Paula Sobrini-Morillo, Celia Corral-Tuesta, Carmen Sánchez-Castellano, Tamara Gutiérrez-Blanco, María Jesús Blanchard-Rodríguez, Belén Escudero-González, Catalina Nieto-Góngora, Jaime Moujir López, José Antonio Serra-Rexach, Alfonso J Cruz-Jentoft

Gerontology · 2025

DOI: 10.1159/000549514 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gerontology, 2025. Verfasst von Paula Sobrini-Morillo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Geriatría, Hospital Universitario Puerta de Hierro de Majadahonda, Madrid, Spain, paula.sobrini@salud.madrid.org. Hauptthemen laut MEDLINE: Sarcopenia, Multiple Myeloma. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Sarcopenia is an age-related condition characterised by low muscle mass and function, associated with poorer outcomes. Its prevalence and prognostic role in multiple myeloma (MM) remain unclear, as most studies only consider muscle mass defined by computed tomography (CT) scan and disregard muscle function. This study aimed to describe the prevalence of sarcopenia according to the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) definition in older patients with MM and to analyse its associations with other geriatric syndromes and survival outcomes.

Methods

This is a prospective study of patients aged ≥65 years with newly diagnosed MM who underwent a Comprehensive Geriatric Assessment (CGA), including handgrip strength and gait speed. Their initial positron emission tomography-computed tomography images were evaluated in terms of muscle mass, subcutaneous and visceral adipose tissue at the third lumbar vertebral level (L3). Medical records were reviewed in January 2025 to collect mortality and follow-up data.

Results

Of 52 patients included (55.1% women; median age 77.6 ± 5.9 years), 32 (61.5%) had probable sarcopenia (low muscle strength), and four (12.5%) had confirmed sarcopenia (low muscle strength and low muscle mass). No significant differences were found in frailty or malnutrition between sarcopenic and non-sarcopenic participants. Sarcopenic patients had significantly shorter overall survival (OS) compared with non-sarcopenic patients (43.1 vs. 18.0 months, p = 0.001), and low muscle mass was independently associated with poorer survival outcomes (hazard ratio [HR]: 46.8; 95% confidence interval [CI]: 1.9–1,146.9). In contrast, no significant differences were observed for progression-free survival (PFS), although low muscle mass remained significantly associated with an increased risk of progression (HR: 25.34; 95% CI: 1.72–374.27).

Conclusion

This is the first study to include both muscle quantity (muscle mass) and function (muscle strength) as the correct approach for sarcopenia evaluation in older patients with MM. Patients with sarcopenia may have reduced OS, and low skeletal muscle mass index was also associated with shorter PFS, but further studies with larger cohorts are needed to confirm its prognostic value.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaMultiple MyelomaHumansAgedFemaleMaleAged, 80 and overProspective StudiesGeriatric AssessmentHand StrengthPrevalencePrognosisWalking SpeedPositron Emission Tomography Computed TomographyMuscle, Skeletal

Stichwörter der Autor:innen

Multiple myelomaMuscle functionMuscle massPhysical performanceSarcopenia

Autor:innen und Institutionen

  • Servicio de Geriatría, Hospital Universitario Puerta de Hierro de Majadahonda, Madrid, Spain, paula.sobrini@salud.madrid.org.
  • Servicio de Geriatría, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
  • Servicio de Hematología, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
  • Servicio de Radiología, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
  • Servicio de Geriatría, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Institute for Health Research of the Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Zitieren

APA

Sobrini-Morillo, P., Corral-Tuesta, C., Sánchez-Castellano, C., Gutiérrez-Blanco, T., Blanchard-Rodríguez, M. J., Escudero-González, B., Nieto-Góngora, C., Moujir López, J., Serra-Rexach, J. A., & Cruz-Jentoft, A. J. (2025). Sarcopenia in Older Patients with Newly Diagnosed Multiple Myeloma. Gerontology. https://doi.org/10.1159/000549514

Vancouver

Sobrini-Morillo P, Corral-Tuesta C, Sánchez-Castellano C, Gutiérrez-Blanco T, Blanchard-Rodríguez MJ, Escudero-González B, et al. Sarcopenia in Older Patients with Newly Diagnosed Multiple Myeloma. Gerontology. 2025. doi:10.1159/000549514

BibTeX
@article{SobriniMorillo2025,
  author = {Sobrini-Morillo, Paula and Corral-Tuesta, Celia and Sánchez-Castellano, Carmen and Gutiérrez-Blanco, Tamara and Blanchard-Rodríguez, María Jesús and Escudero-González, Belén and Nieto-Góngora, Catalina and Moujir López, Jaime and Serra-Rexach, José Antonio and Cruz-Jentoft, Alfonso J},
  title = {Sarcopenia in Older Patients with Newly Diagnosed Multiple Myeloma},
  journal = {Gerontology},
  year = {2025},
  doi = {10.1159/000549514}
}
Kostenlos starten →